By Staff Reports
(DGIwire) – Often, when we hear the term artificial intelligence (AI), we think of robots performing routine jobs. In fact, AI is actually a computer code or algorithm that can imitate human behavior without even taking on physical form. Its applications are virtually limitless. In his “Bits” column in The New York Times, Pulitzer Prize-winning journalist Steve Lohr has discussed the possibility that in the future, human writers—including himself—might be out of work as a result of AI. As he notes, there already exists software that takes data on subjects such as sports, statistics and financial reports and turns it into articles indistinguishable from the ones he writes.
Lohr is concerned that although AI programs will continue to assist humans by increasing efficiency and accuracy, they can also conceivably replace writers altogether. Many articles published online are already generated this way, he observes. For some sporting events, AI algorithms use data entered by people attending the games, ensuring their accuracy and timeliness. Other AI experts also believe that story-writing algorithms are just the beginning, and will eventually become the norm in the news industry— potentially even winning a Pulitzer Prize.
The good news is that humans are still an essential element, since they create the software that directs how AI programs decide what to write. Also, the emotion, irony and tone that colors a story and brings it to life can’t be incorporated into software, so writers are safe—at least for now.
Meanwhile, Stevia First Corp., an agricultural biotechnology company based in California, is using AI to improve its research and development efforts through an “AI Scientist” platform. The Company is starting with AI algorithms that have been proven useful to life sciences R&D, including ones to enable enzyme and gene discovery to better understand the biochemistry of the stevia plant. But it is also combining these AI algorithms and databases into a generalized AI platform, which learns as it goes, and becomes more powerful as new algorithms and databases are implemented all within the same system.
The Company’s goal is to improve the efficiency of its proprietary stevia bioprocessing methods, strengthen its patent portfolio, and also to use its interdisciplinary R&D team to explore new commercial applications of the “AI Scientist” platform.
Robert Brooke, Stevia First’s CEO, says, “We’ve made progress on our work to date, which has been primarily directed at using proven AI algorithms to strengthen our existing R&D programs. What is exciting about our ‘AI Scientist’ platform is how we are continuing to build it, where it becomes much more powerful as we add new tools and expertise within the system. This is an exciting opportunity with significant potential for future growth.”